Study Stopped
PATH withdrew IRB approval
Effectiveness, Safety and Feasibility of Auxiliary Nurse Midwives' (ANM) Use of Oxytocin in Uniject™ to Prevent Postpartum Hemorrhage in India
Assessing the Effectiveness, Safety and Feasibility of Expanding Use of Oxytocin in Uniject™ by Auxiliary Nurse Midwives to Prevent Postpartum Hemorrhage: A Community-based Cluster Randomized Trial in Bagalkot, India
1 other identifier
interventional
N/A
1 country
1
Brief Summary
This cluster randomized community-based trial is designed to test the hypothesis that the intramuscular administration of 10 IU of oxytocin in Uniject™ during the third stage of labor by an Auxiliary Nurse Midwife (ANM) at births occurring in homes, Sub-Centers and Primary Health Centers in Bagalkot, India will reduce the risk of postpartum hemorrhage by 44% (from 9% to 5%) relative to home births attended by the same type of provider who does not provide the intervention drug. The study will also document correct use of oxytocin in Uniject, adverse maternal and fetal events associated with inappropriate use and a number of indicators reflecting the programmatic feasibility of implementing this intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 2, 2010
CompletedFirst Posted
Study publicly available on registry
April 21, 2010
CompletedStudy Start
First participant enrolled
September 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedJanuary 9, 2012
December 1, 2011
1.8 years
April 2, 2010
January 6, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
postpartum hemorrhage
blood loss \>=500 ml after delivery of the baby, as measured through a plastic calibrated drape.
after delivery of baby
Secondary Outcomes (4)
Oxytocin use before delivery
labor and delivery
stillbirth
pregnancy
neonatal death
first month of life
need for neonatal resuscitation
0-6 hours after birth
Study Arms (2)
PPH Treatment only
NO INTERVENTIONAuxilliary nurse midwives will be able to treat for PPH only, not provide Oxytocin in Uniject
Oxytocin in Uniject
EXPERIMENTALAuxilliary Nurse Midwives will provide 10IU Oxytocin in Uniject device IM immediately after delivery
Interventions
10 IU Oxytocin delivered intramuscularly immediately after delivery of the baby
Eligibility Criteria
You may qualify if:
- gestational age \>=28 wks at enrollment
- anticipate spontaneous vaginal delivery
- hemoglobin \>=8 gm/dl
- delivery at home, sub-center, or primary health center
- delivery attended by Auxilliary Nurse Midwife
You may not qualify if:
- previous caesarean-section
- scheduled for caesarean-section
- antepartum bleeding during current pregnancy
- blood pressure \>140mm of Hg systolic and \>90mm of Hg diastolic
- in active labor at time of recruitment
- high risk medical conditions (diabetes, cardiac ailments, seizures, placenta previa, anticipated breech delivery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Bloomberg School of Public Healthlead
- Jawaharlal Nehru Medical College Women's and Children's Health Research Unitcollaborator
- PATHcollaborator
- Bill and Melinda Gates Foundationcollaborator
Study Sites (1)
Jawaharlal Nehru Medical College Women's and Children's Health Research Unit
Belagavi, Karnataka, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cynthia Stanton, PhD
Johns Hopkins Bloomberg School of Public Health
- PRINCIPAL INVESTIGATOR
Shivaprasad Goudar, MD
JN Medical College, Belgaum, India
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 2, 2010
First Posted
April 21, 2010
Study Start
September 1, 2011
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
January 9, 2012
Record last verified: 2011-12